NCT06032637

Best Incision in Cesarean Section of Obese Women

Completed NA Last updated 20 February 2024

What this trial tests

NA trial testing Pfannenstiel incision in Morbid Obesity in 60 participants. Completed in 30 October 2023.

Timeline

1 August 2022

Primary endpoint
1 October 2023

30 October 2023

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 August 2022
Primary completion	1 October 2023
Estimated completion	30 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

• Pfannenstiel incision
• Supra-umbilical transverse incision

Conditions studied

• Morbid Obesity — all drugs for Morbid Obesity →
• Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

Al-Azhar University

Who can join

Adults 20 to 40, female only, with Morbid Obesity or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this comparative clinical trial is to compare Pfannenstiel incision and higher transverse supra umbilical incision techniques during elective cesarean section in morbidly obese patients. The main questions it aims to answer are:

Is there a difference in operative time between the two incision techniques? Is there a difference in estimated blood loss between the two techniques? Is there a difference in post-operative pain scores between the two techniques? Is there a difference in wound complication rates between the two techniques? Participants will be randomly assigned to receive either a Pfannenstiel incision or a higher transverse supra umbilical incision during their scheduled cesarean delivery.

Researchers will compare the Pfannenstiel incision group to the higher transverse supra umbilical incision group to see if there are differences in operative time, blood loss, post-operative pain, and wound complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.